Soclenicant

N/A

Report date: 2025/12/29 10:27:28
NME

Base Information

Drug NameSoclenicant
Drug Alias NameBNC-210IW-2143
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit modulators
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsAgitationStress Disorders, Post-TraumaticPhobia, Social
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBionomics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBionomics Ltd
Inactive CompaniesNeuphoria Therapeutics Inc
Active IndicationsStress Disorders, Post-Traumatic
Inactive IndicationsAgitationPhobia, Social

Other Information

ATC CodeN/A
Related LinksWikipedia